Meloxicam and Parnaparin: Interaction Details

Brand names
Meloxicam
MobicVivlodexQmiiz +4 more
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Meloxicam

Brand names
  • Mobic
  • Vivlodex
  • Qmiiz
  • Anjeso
  • Xifyrm
  • Qamzova
  • Zybic

Parnaparin

We don't have a drug information page for Parnaparin yet. Have a question about Parnaparin? Ask a pharmacist, free →

What Happens When You Take Meloxicam With Parnaparin

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving together with low-molecular-weight heparins (LMWH) or heparinoids can raise the likelihood of serious bleeding, among them epidural or spinal hematomas in patients undergoing neuraxial anesthesia or spinal puncture. Where feasible, the should be stopped before LMWH therapy is started.2 When an LMWH and an NSAID must be used together, the patient should be watched closely for signs and symptoms of bleeding, and extreme caution is advised.1

The Meloxicam and Parnaparin Interaction, Explained

Meloxicam is an anti-inflammatory pain reliever (an ), and parnaparin is a given by injection to help prevent or treat clots. Taken together, they can raise your chance of bleeding. Meloxicam makes work less well, and parnaparin slows your blood's ability to clot, so the two effects add up.

This can matter a lot if you are having spinal or epidural anesthesia or a spinal puncture, because bleeding near the spine is rare but serious. Please do not stop or change either medicine on your own. Tell your pharmacist or doctor you take both. Your care team can decide whether you need meloxicam at all and will watch you closely for any signs of bleeding.

hemostatic impairment (PD interaction). Meloxicam (, COX ) reduces function, while parnaparin (LMWH) potentiates antithrombin-mediated inhibition of factor Xa and thrombin. Combined use increases the risk of major bleeding, including epidural or spinal hematoma with neuraxial anesthesia or spinal puncture.

  • Severity/evidence: major; probable. Onset unspecified.
  • Management: discontinue the NSAID before starting LMWH when possible.
  • If is necessary, use extreme caution and monitor closely for signs and symptoms of bleeding, with particular vigilance around neuraxial procedures.

See the 6 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Meloxicam and Parnaparin Interact

The likely mechanism

Decreased function; decreased coagulation

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Meloxicam and Parnaparin Interaction

The usual approach is to stop the before LMWH therapy begins when possible. Your care team will decide whether that is right for you.

  • If you need both, your team will use extra caution and monitor you closely for bleeding.
  • Keep taking your medicines exactly as prescribed unless your prescriber tells you otherwise.
  • Tell your pharmacist or prescriber about both drugs, especially before any spinal or epidural procedure.
  • Ask them which bleeding signs to watch for and when to seek help.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Meloxicam or Parnaparin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Epidural hematoma in an ambulatory surgical patient

    A 60-year-old woman who was taking aspirin, naproxen, nifedipine, captopril, cimetidine, and potassium supplements was scheduled for an ambulatory arthroscopic lateral meniscectomy. She was given 30 mg of a low-molecular-weight heparin 90 minutes before epidural anesthesia was started.

    The surgery was uneventful, and she was sent home with full motor and sensory function. About 2 hours afterward she developed excruciating lumbar back pain, and she came back to the hospital 90 minutes after that.

    By then she had lost motor function in her lower extremities. Computerized tomography showed an epidural hematoma, which was then removed in emergency surgery.

    By the second postoperative day she had recovered full motor and sensory function. Aspirin, , and low-molecular-weight heparin are each regarded as safe when given alone before a neuraxial block, but it was judged that the combination of all 3 agents in this patient led to the epidural hematoma.3

  2. Report 2 · Study title

    Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?

    Sixty patients undergoing total hip replacement were randomized into 2 groups to assess whether of enoxaparin and ketorolac could cause excessive postoperative bleeding. Any previous therapy had been stopped 4 weeks before surgery.

    All patients were given enoxaparin 40 mg subcutaneously 12 hours before surgery and then once daily for 10 days. Twenty-six patients also received ketorolac 30 mg intramuscularly at of anesthesia, followed by 30 mg once daily for 4 days.

    The remaining 34 patients received enoxaparin along with and acetaminophen analgesia. The groups did not differ significantly in intraoperative blood loss, postoperative drainage, transfusion requirements, wound oozing, bruising, or leg swelling.

    In addition, no patient had a clinically detectable . The authors proposed that the risk of increased bleeding from combining a low-molecular-weight heparin with an NSAID is low, as long as the NSAID dose is modest.4

  3. Report 3 · Study title

    Increased blood loss after preoperative NSAID

    In a retrospective study of patients given enoxaparin during hip replacement surgery, perioperative blood loss and blood transfusion use were significantly greater in patients who had used before surgery than in those who had not. The 2 groups did not differ in postoperative blood loss.5

  4. Report 4 · Study title

    Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis

    Twenty-four healthy male volunteers aged 18 to 55 years received all 4 combinations of ketorolac/placebo and dalteparin/placebo in a double-blind, placebo-controlled, randomized, crossover study of the hemostatic interaction between ketorolac and dalteparin. Ketorolac inhibited aggregation in whole blood and in platelet-rich plasma, and as a result lengthened the skin bleeding time.

    After dalteparin administration, antifactor Xa levels rose significantly and the activated partial thromboplastin time was significantly prolonged, although values stayed within the range of the normal population. Ketorolac and dalteparin interacted to prolong bleeding time, whereas dalteparin alone did not affect bleeding time. complications may be possible in the perioperative period when dalteparin and ketorolac are given together.6

Meloxicam and Parnaparin: Common Questions

How serious is the Meloxicam and Parnaparin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Meloxicam and Parnaparin interaction managed?

The usual approach is to stop the before LMWH therapy begins when possible. Your care team will decide whether that is right for you. If you need both, your team will use extra caution and monitor you closely for bleeding. Keep taking your medicines exactly as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or prescriber about both drugs, especially before any spi… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Meloxicam and Parnaparin Interaction

Ask in your own words about taking Meloxicam and Parnaparin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (6)

  1. Product Information: SPRIX(TM) nasal spray, ketorolac tromethamine nasal spray. Roxro Pharma, Inc, Menlo Park, CA, 2009. DailyMed
  2. Product Information: Lovenox(R) subcutaneous injection, intravenous injection, enoxaparin sodium subcutaneous injection, intravenous injection. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  3. Porterfield WR & Wu CL: Epidural hematoma in an ambulatory surgical patient. J Clin Anesth 1997; 9:74-76. PubMed
  4. Weale AE, Warwick DJ, Durant N, et al: Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?. Ann R Coll Surg Engl 1995; 77:35-37.
  5. Fauno P, Petersen KD, & Husted SE: Increased blood loss after preoperative NSAID. Acta Orthop Scand 1993; 64:522-524.
  6. Greer IA, Gibson JL, Young A, et al: Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis. Blood Coagul Fibrinolysis 1999; 10:367-373. PubMed
Was this write-up helpful?

Other Serious Interactions of Meloxicam and Parnaparin

Also serious with Meloxicam

Also serious with Parnaparin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Meloxicam

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.